[go: up one dir, main page]

AR099029A1 - MODULADORES DE PIRROLIDINILSULFONA RORg - Google Patents

MODULADORES DE PIRROLIDINILSULFONA RORg

Info

Publication number
AR099029A1
AR099029A1 ARP150100016A ARP150100016A AR099029A1 AR 099029 A1 AR099029 A1 AR 099029A1 AR P150100016 A ARP150100016 A AR P150100016A AR P150100016 A ARP150100016 A AR P150100016A AR 099029 A1 AR099029 A1 AR 099029A1
Authority
AR
Argentina
Prior art keywords
cr2er2f
substituted
alkyl
nr11r11
occurrence
Prior art date
Application number
ARP150100016A
Other languages
English (en)
Inventor
G Murali Dhar T
Lu Zhonghui
Xiao Hai
Yun - Duan Jingwu
Jiang Bin
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR099029A1 publication Critical patent/AR099029A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto caracterizado porque tiene la fórmula (1), o uno de sus estereoisómeros sales farmacéuticamente aceptables, en donde: R¹ se selecciona de H, halo, alquilo C₁₋₆ sustituido con 0 - 3 R¹ᵃ y -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 14 miembros sustituido con 0 - 3 R¹ᵃ; R¹ᵃ es, de modo independiente en cada aparición, hidrógeno, =O, halo, CF₃, OCF₃, CN, NO₂, -(CR²ᵉR²ᶠ)ʳ-ORᵇ, -(CR²ᵉR²ᶠ)ʳ-S(O)ₚRᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)ORᵇ, -(CR²ᵉR²ᶠ)ʳ-OC(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-C(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)Rᶜ, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)ORᶜ, -NRᵇC(O)NR¹¹R¹¹, -S(O)ₚNR¹¹R¹¹, -NRᵇS(O)ₚRᶜ, alquilo C₁₋₆ sustituido con 0 - 3 Rᵃ, haloalquilo C₁₋₆, alquenilo C₂₋₆ sustituido con 0 - 3 Rᵃ, alquinilo C₂₋₆ sustituido con 0 - 3 Rᵃ, -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 14 miembros sustituido con 0 - 3 Rᵃ o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᵃ; R² se selecciona de hidrógeno, -(CR²ᵉR²ᶠ)ʳ-C(O)R²ᵈ, -(CR²ᵉR²ᶠ)ʳ-C(O)OR²ᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-S(O)₂R²ᶜ, alquilo C₁₋₆ sustituido con 0 - 3 R²ᵃ, alquenilo C₂₋₆ sustituido con 0 - 3 R²ᵃ, -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 10 miembros sustituido con 0 - 3 Rᵃ y -(CR²ᵉR²ᶠ)ʳ-heterociclo de 4 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᵃ; R²ᵃ es, de modo independiente en cada aparición, hidrógeno, =O, halo, OCF₃, CN, NO₂, -(CR²ᵉR²ᶠ)ʳ-ORᵇ, -(CR²ᵉR²ᶠ)ʳ-S(O)ₚRᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)ORᵇ, -(CR²ᵉR²ᶠ)ʳ-OC(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-C(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)Rᶜ, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)ORᶜ, -NRᵇC(O)NR¹¹R¹¹, -S(O)ₚNR¹¹R¹¹, -NRᵇS(O)ₚRᶜ, alquilo C₁₋₆ sustituido con 0 - 3 Rᵃ, haloalquilo C₁₋₆, alquenilo C₂₋₆ sustituido con 0 - 3 Rᵃ, alquinilo C₂₋₆ sustituido con 0 - 3 Rᵃ, -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 14 miembros sustituido con 0 - 3 Rᵃ o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 4 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᵃ; R²ᵇ es, de modo independiente en cada aparición, hidrógeno, CF₃, -(CR²ᵉR²ᶠ)qORᵇ, -(CR²ᵉR²ᶠ)qS(O)ₚRᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)R¹ᵈ, -(CR²ᵉR²ᶠ)ʳ-C(O)ORᵇ, -(CR²ᵉR²ᶠ)qOC(O)Rᵇ, -(CR²ᵉR²ᶠ)qNR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-C(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)qNRᵇC(O)R¹ᶜ, -(CR²ᵉR²ᶠ)qNRᵇC(O)ORᶜ, -(CR²ᵉR²ᶠ)qNRᵇC(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)qS(O)₂NR¹¹R¹¹, -(CR²ᵉR²ᶠ)qNRᵇS(O)₂Rᶜ, alquilo C₁₋₆ sustituido con 0 - 2 Rᵃ, haloalquilo C₁₋₆, -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 14 miembros sustituido con 0 - 3 Rᵃ o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 2 Rᵃ; R²ᶜ es, de modo independiente en cada aparición, hidrógeno, alquilo C₁₋₆ sustituido con 0 - 3 Rᵃ, alquenilo C₂₋₆ sustituido con 0 - 3 Rᵃ, cicloalquilo C₃₋₁₀ sustituido con 0 - 3 Rᵃ, arilo C₆₋₁₀ sustituido con 0 - 3 Rᵃ o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 10 miembros que contiene 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ, sustituido con 0 - 3 Rᵃ; R²ᵈ es, de modo independiente en cada aparición, hidrógeno, alquilo C₁₋₆ sustituido con 0 - 2 Rᵈ, haloalquilo C₁₋₆, C₍O₎NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-cicloalquilo C₃₋₁₀ sustituido con 0 - 3 Rᵈ, -(CR²ᵉR²ᶠ)ʳ-fenilo sustituido con 0 - 2 Rᵃ o un -(CR²ᵉR²ᶠ)ʳ-heterociclo de 4 - 10 miembros donde el heterociclo puede ser fusionado, en puente o espirocíclico, que contiene 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ, sustituido con 0 - 3 Rᵃ; R²ᵉ y R²ᶠ son, de modo independiente en cada aparición, hidrógeno, halógeno o alquilo C₁₋₆; R³ se selecciona de hidrógeno, halo, N₃, CN, -(CR²ᵉR²ᶠ)ʳ-OR³ᵇ, -(CR²ᵉR²ᶠ)ʳ-NR¹¹R¹¹, alquilo C₁₋₆ sustituido con 0 - 3 R³ᵃ, cicloalquilo C₃₋₁₀ sustituido con 0 - 3 R³ᵃ; y fenilo sustituido con 0 - 3 R³ᵃ o heterociclo de 4 - 10 miembros que contiene 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ, sustituido con 0 - 3 R³ᵃ o dos R³ ubicados en átomos de carbono adyacentes ligados para formar un carbociclo de 5 - 7 miembros o un heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ, ambos opcionalmente sustituidos con 0 - 3 R³ᵃ; R³ᵃ es, de modo independiente en cada aparición, hidrógeno, =O, halo, OCF₃, OCF₂, CF₃, CHF₂, CN, NO₂, -(CR²ᵉR²ᶠ)ʳ-ORᵇ, -(CR²ᵉR²ᶠ)ʳ-S(O)ₚRᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)ORᵇ, -(CR²ᵉR²ᶠ)ʳ-OC(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-C(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)Rᶜ, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)ORᶜ, -NRᵇC(O)NR¹¹R¹¹, -S(O)ₚNR¹¹R¹¹, -NRᵇS(O)ₚRᶜ, alquilo C₁₋₆ sustituido con 0 - 3 Rᵃ, alquenilo C₂₋₆, sustituido con 0 - 3 Rᵃ, alquinilo C₂₋₆ sustituido con 0 - 3 Rᵃ, haloalquilo C₁₋₆, -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 14 miembros sustituido con 0 - 3 Rᵃ o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 10 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᵃ; R³ᵇ es, de modo independiente en cada aparición, hidrógeno, CF₃, -(CR²ᵉR²ᶠ)qORᵇ, -(CR²ᵉR²ᶠ)qS(O)ₚRᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)R¹ᵈ, -(CR²ᵉR²ᶠ)ʳ-C(O)ORᵇ, -(CR²ᵉR²ᶠ)qOC(O)Rᵇ, -(CR²ᵉR²ᶠ)qNR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-C(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)qNRᵇC(O)R¹ᶜ, -(CR²ᵉR²ᶠ)qNRᵇC(O)ORᶜ, -(CR²ᵉR²ᶠ)qNRᵇC(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)qS(O)₂NR¹¹R¹¹, (CR²ᵉR²ᶠ)qNRᵇS(O)₂Rᶜ, alquilo C₁₋₆, sustituido con 0 - 3 Rᵃ, haloalquilo C₁₋₆, -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 14 miembros sustituido con 0 - 3 Rᵃ o-(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᵃ; R¹¹ es, de modo independiente en cada aparición, hidrógeno, alquilo C₁₋₆ sustituido con 0 - 3 Rᶠ, CF₃, cicloalquilo C₃₋₁₀ sustituido con 0 - 3 Rᶠ, -(CR²ᵉR²ᶠ)ʳ-fenilo sustituido con 0 - 3 Rᵈ o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᵈ; o un R¹¹ y un segundo R¹¹, ambos unidos al mismo átomo de nitrógeno, se combinan para formar un heterociclo que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᵈ; Rᵃ es, de modo independiente en cada aparición, hidrógeno, =O, halo, OCF₃, CF₃, CHF₂, CN, NO₂, -(CR²ᵉR²ᶠ)ʳ-ORᵇ, -(CR²ᵉR²ᶠ)ʳ-S(O)ₚRᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-C(O)ORᵇ, -(CR²ᵉR²ᶠ)ʳ-OC(O)Rᵇ, -(CR²ᵉR²ᶠ)ʳ-NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-C(O)NR¹¹R¹¹, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)Rᶜ, -(CR²ᵉR²ᶠ)ʳ-NRᵇC(O)ORᶜ, -NRᵇC(O)NR¹¹R¹¹, -S(O)ₚNR¹¹R¹¹, -NRᵇS(O)ₚRᶜ, alquilo C₁₋₆ sustituido con 0 - 3 Rᶠ, haloalquilo C₁₋₆, alquenilo C₂₋₆, sustituido con 0 - 3 Rᵃ, alquinilo C₂₋₆ sustituido con 0 - 3 Rᵃ, -(CR²ᵉR²ᶠ)ʳ-carbociclo de 3 - 14 miembros o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᶠ; Rᵇ es, de modo independiente en cada aparición, hidrógeno, alquilo C₁₋₆ sustituido con 0 - 3 Rᵈ, haloalquilo C₁₋₆, cicloalquilo C₃₋₆,sustituido con 0 - 3 Rᵈ, -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᶠ o -(CR²ᵉR²ᶠ)ʳ-carbociclo de 6 - 10 miembros sustituido con 0 - 3 Rᵈ; Rᶜ es, de modo independiente en cada aparición, alquilo C₁₋₆ sustituido con 0 - 3 Rᶠ, -(CR²ᵉR²ᶠ)ʳ-cicloalquilo C₃₋₆ sustituido con 0 - 3 Rᶠ o -(CR²ᵉR²ᶠ)ʳ-fenilo sustituido con 0 - 3 Rᶠ; Rᵈ es, de modo independiente en cada aparición, hidrógeno, =O, halo, OCF₃ CF₃, CN, NO₂, -ORᵉ, -(CR²ᵉR²ᶠ)ʳ-C(O)Rᶜ, -NRᵉRᵉ, -NRᵉC(O)ORᶜ, C(O)NRᵉRᵉ, -NRᵉC(O)Rᶜ, CO₂Rᶜ, -NRᵉSO₂Rᶜ, SO₂Rᶜ, alquilo C₁₋₆ sustituido con 0 - 3 Rᶠ, cicloalquilo C₃₋₆ sustituido con 0 - 3 Rᶠ, -(CR²ᵉR²ᶠ)ʳ-fenilo sustituido con 0 - 3 Rᶠ o -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 7 miembros que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ sustituido con 0 - 3 Rᶠ; Rᵉ está seleccionado, de modo independiente en cada aparición, de hidrógeno, C(O)NRᶠRᶠ, alquilo C₁₋₆, cicloalquilo C₃₋₆ o -(CR²ᵉR²ᶠ)ʳ-fenilo sustituido con 0 - 3 Rᶠ; Rᶠ es, de modo independiente en cada aparición, hidrógeno, =O, halo, CN, NH₂, NH(alquilo C₁₋₆), N(alquilo C₁₋₆)₂, SO₂(alquilo C₁₋₆), CO₂H, CO₂(alquilo C₁₋₆), OH, cicloalquilo C₃₋₆, CF₃ u O(alquilo C₁₋₆); o Rᶠ es, de modo independiente en cada aparición, un -(CR²ᵉR²ᶠ)ʳ-heterociclo de 5 - 10 miembros opcionalmente sustituido que comprende átomos de carbono y 1 - 4 heteroátomos seleccionados de N, O y S(O)ₚ, fenilo o cicloalquilo C₃₋₆, cada grupo opcionalmente sustituido con halo, CN, CF₃, alquilo C₁₋₆ u O(alquilo C₁₋₆); m y n se seleccionan, de modo independiente, de 0, 1, 2 y 3; p y q, independientemente de cada aparición, son 0, 1 ó 2; y r es 0, 1, 2, 3 ó 4.
ARP150100016A 2014-01-06 2015-01-06 MODULADORES DE PIRROLIDINILSULFONA RORg AR099029A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461923896P 2014-01-06 2014-01-06

Publications (1)

Publication Number Publication Date
AR099029A1 true AR099029A1 (es) 2016-06-22

Family

ID=52359012

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100016A AR099029A1 (es) 2014-01-06 2015-01-06 MODULADORES DE PIRROLIDINILSULFONA RORg

Country Status (11)

Country Link
US (2) US20160326108A1 (es)
EP (1) EP3092229B1 (es)
JP (1) JP6530764B2 (es)
CN (1) CN106061971B (es)
AR (1) AR099029A1 (es)
CA (1) CA2936116A1 (es)
EA (1) EA030849B1 (es)
ES (1) ES2669208T3 (es)
MX (1) MX369347B (es)
TW (1) TW201609634A (es)
WO (1) WO2015103509A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105705501B (zh) 2013-09-09 2019-04-19 百时美施贵宝公司 RORγ调节剂
JP6397488B2 (ja) 2013-09-20 2018-09-26 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ ＲＯＲγ調節因子
JP6476205B2 (ja) 2014-01-06 2019-02-27 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ ＲＯＲγ修飾因子としてのヘテロ環式スルホン
CN106132931B (zh) 2014-01-06 2019-08-02 百时美施贵宝公司 碳环砜RORγ调节剂
CN106061947B (zh) 2014-01-06 2019-12-03 百时美施贵宝公司 环己基砜RORγ调节剂
SI3212641T1 (sl) 2014-10-30 2019-02-28 Janssen Pharmaceutica Nv Tiazoli kot modulatorji RORyt
JOP20200117A1 (ar) 2014-10-30 2017-06-16 Janssen Pharmaceutica Nv كحولات ثلاثي فلوروميثيل كمُعدلات للمستقبل النووي جاما تي المرتبط بحمض الريتيونَويك ROR?t
US9845319B2 (en) 2014-10-30 2017-12-19 Janssen Pharmaceutiuca NV Amide substituted thiazoles as modulators of RORyt
PE20180119A1 (es) 2015-05-07 2018-01-18 Bristol Myers Squibb Co Sulfonas triciclicas como moduladores del receptor huerfano relacionado con retinoide gamma (rorgamma)
US10610520B2 (en) 2016-03-31 2020-04-07 Takeda Pharmaceutical Company Limited Heterocyclic compound
TW201803869A (zh) 2016-04-27 2018-02-01 健生藥品公司 作為ＲＯＲγＴ調節劑之６－胺基吡啶－３－基噻唑
EP3523279A1 (en) * 2016-10-10 2019-08-14 Bristol-Myers Squibb Company Tricyclic sulfones as ror gamma modulators
WO2018071620A1 (en) * 2016-10-13 2018-04-19 Bristol-Myers Squibb Company Heterocyclic sulfones as ror gamma modulators
AU2017356911A1 (en) * 2016-11-09 2019-06-20 Bristol-Myers Squibb Company Tricyclic sulfones as ROR gamma modulators
EP3538522A1 (en) * 2016-11-10 2019-09-18 Bristol-Myers Squibb Company Ror gamma modulators
CA3103770A1 (en) 2018-06-18 2019-12-26 Janssen Pharmaceutica Nv Phenyl and pyridinyl substituted imidazoles as modulators of roryt
JP2021528405A (ja) 2018-06-18 2021-10-21 ヤンセン ファーマシューティカ エヌ．ベー． ＲＯＲγｔのモジュレータとしてのアミド置換チアゾール
US11034658B2 (en) 2018-06-18 2021-06-15 Janssen Pharmaceutica Nv Pyridinyl pyrazoles as modulators of RORγT
US10975057B2 (en) 2018-06-18 2021-04-13 Janssen Pharmaceutica Nv 6-aminopyridin-3-yl pyrazoles as modulators of RORgT
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
US12012374B2 (en) 2019-05-13 2024-06-18 Bristol-Myers Squibb Company Agonists of ROR GAMMAt

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108591D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
JP2014518267A (ja) 2011-06-27 2014-07-28 杏林製薬株式会社 細菌感染症の治療のための架橋二環式化合物
US20130190356A1 (en) * 2011-12-22 2013-07-25 Genentech, Inc. Benzyl sulfonamide derivatives as rorc modulators
CA2871504C (en) * 2012-05-08 2020-07-21 Merck Sharp & Dohme Corp. Bicyclic sulfone compounds for inhibition of rorgamma activity and the treatment of disease
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
WO2014028669A1 (en) * 2012-08-15 2014-02-20 Biogen Idec Ma Inc. Novel compounds for modulation of ror-gamma activity
CN106132931B (zh) 2014-01-06 2019-08-02 百时美施贵宝公司 碳环砜RORγ调节剂
JP6476205B2 (ja) 2014-01-06 2019-02-27 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ ＲＯＲγ修飾因子としてのヘテロ環式スルホン
CN106061947B (zh) 2014-01-06 2019-12-03 百时美施贵宝公司 环己基砜RORγ调节剂

Also Published As

Publication number Publication date
US9458171B2 (en) 2016-10-04
ES2669208T3 (es) 2018-05-24
CA2936116A1 (en) 2015-07-09
US20160326108A1 (en) 2016-11-10
MX369347B (es) 2019-11-06
EP3092229A1 (en) 2016-11-16
CN106061971A (zh) 2016-10-26
US20150191483A1 (en) 2015-07-09
EP3092229B1 (en) 2018-03-28
MX2016008845A (es) 2016-09-07
EA030849B1 (ru) 2018-10-31
WO2015103509A1 (en) 2015-07-09
CN106061971B (zh) 2019-03-12
JP6530764B2 (ja) 2019-06-12
EA201691368A1 (ru) 2016-10-31
JP2017501236A (ja) 2017-01-12
TW201609634A (zh) 2016-03-16

Similar Documents

Publication Publication Date Title
AR099029A1 (es) MODULADORES DE PIRROLIDINILSULFONA RORg
AR104555A1 (es) SULFONAS TRICÍCLICAS COMO MODULARES DE RORg
CY1124187T1 (el) Ετεροκυκλικα αμιδια ως αναστολεις κινασης
AR093020A1 (es) Compuestos antiviricos para el vsr
AR093403A1 (es) COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA UTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL23 Y/O INFa
AR094537A1 (es) COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa
AR108222A1 (es) Compuestos heteroaril-1,2,4-triazol y heteroaril-tetrazol
AR105050A1 (es) Procesos para preparar compuestos antivirales
AR109805A1 (es) Derivados de oxadiazol microbiocidas
AR100312A1 (es) Compuestos de diaminotriazina
AR095208A1 (es) Pirrolotriazinas como inhibidores del canal del ión potasio
AR091273A1 (es) Inhibidores de pirimidinil tirosina quinasa
AR101586A1 (es) Derivados heterocíclicos con sustituyentes que contienen azufre activos como plaguicidas
AR094452A1 (es) COMPUESTOS HETEROCÍCLICOS SUSTITUIDOS CON AMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O INFa
AR095192A1 (es) Quinolina y quinazolinamidas como modulares de canales de sodio
AR095339A1 (es) Compuestos moduladores alostericos de la hemoglobina
AR091737A1 (es) Inhibicion de enzimas
AR094852A1 (es) Oestra-1,3,5(10),16-tetraeno-3-carboxamidas
AR091455A1 (es) Derivados 1,3-dihidro-2h-benzimidazol-2-ona sustituidos con heterociclos como agentes antivirales para el virus sincicial respiratorio
CY1114354T1 (el) Νεα παραγωγα βενζαμιδιου ως ανταγωνιστες βραδυκινινης
MX2019011774A (es) N-(-1,3,4-oxadiazol-2-il)arilcarboxamidas sustituidas y su uso como herbicidas.
AR094159A1 (es) Compuesto de [1,2,4]triazol e imidazol sustituidos
AR089814A1 (es) Compuestos que modulan la actividad de los proteasomas
AR101906A1 (es) 1,3,4-tiadiazoles que tienen actividad herbicida, sus composiciones agronómicas y uso relacionado
AR101589A1 (es) Derivados de iminonitrilo

Legal Events

Date Code Title Description
FB Suspension of granting procedure